Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study)

Takeshi Nakahara; Kenji Izuhara; Daisuke Onozuka; Hidehisa Saeki; Satoshi Nunomura; Motoi Takenaka; Mai Matsumoto; Yoko Kataoka; Rai Fujimoto; Sakae Kaneko; Eishin Morita; Akio Tanaka; Michihiro Hide; Tatsuro Okano; Tomomitsu Miyagaki; Natsuko Aoki; Kimiko Nakajima; Susumu Ichiyama; Makiko Kido-Nakahara; Kyoko Tonomura; Yukinobu Nakagawa; Risa Tamagawa-Mineoka; Koji Masuda; Takuya Takeichi; Masashi Akiyama; Yozo Ishiuji; Michie Katsuta; Yuki Kinoshita; Chiharu Tateishi; Aya Yamamoto; Akimichi Morita; Haruna Matsuda-Hirose; Yutaka Hatano; Hiroshi Kawasaki; Keiji Tanese; Mamitaro Ohtsuki; Koji Kamiya; Yudai Kabata; Riichiro Abe; Hiroshi Mitsui; Tatsuyoshi Kawamura; Gaku Tsuji; Norito Katoh; Masutaka Furue

doi:10.1111/cea.14267

Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study)

Takeshi Nakahara, Kenji Izuhara, Daisuke Onozuka, Hidehisa Saeki, Satoshi Nunomura, Motoi Takenaka, Mai Matsumoto, Yoko Kataoka, Rai Fujimoto, Sakae Kaneko, Eishin Morita, Akio Tanaka, Michihiro Hide, Tatsuro Okano, Tomomitsu Miyagaki, Natsuko Aoki, Kimiko Nakajima, Susumu Ichiyama, Makiko Kido-Nakahara, Kyoko TonomuraYukinobu Nakagawa, Risa Tamagawa-Mineoka, Koji Masuda, Takuya Takeichi, Masashi Akiyama, Yozo Ishiuji, Michie Katsuta, Yuki Kinoshita, Chiharu Tateishi, Aya Yamamoto, Akimichi Morita, Haruna Matsuda-Hirose, Yutaka Hatano, Hiroshi Kawasaki, Keiji Tanese, Mamitaro Ohtsuki, Koji Kamiya, Yudai Kabata, Riichiro Abe, Hiroshi Mitsui, Tatsuyoshi Kawamura, Gaku Tsuji, Norito Katoh, Masutaka Furue

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	233-238
Number of pages	6
Journal	Clinical and Experimental Allergy
Volume	53
Issue number	2
DOIs	https://doi.org/10.1111/cea.14267
Publication status	Published - Feb 2023

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Immunology

Access to Document

10.1111/cea.14267

Cite this

Nakahara, T., Izuhara, K., Onozuka, D., Saeki, H., Nunomura, S., Takenaka, M., Matsumoto, M., Kataoka, Y., Fujimoto, R., Kaneko, S., Morita, E., Tanaka, A., Hide, M., Okano, T., Miyagaki, T., Aoki, N., Nakajima, K., Ichiyama, S., Kido-Nakahara, M., ... Furue, M. (2023). Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study). Clinical and Experimental Allergy, 53(2), 233-238. https://doi.org/10.1111/cea.14267

Nakahara, T, Izuhara, K, Onozuka, D, Saeki, H, Nunomura, S, Takenaka, M, Matsumoto, M, Kataoka, Y, Fujimoto, R, Kaneko, S, Morita, E, Tanaka, A, Hide, M, Okano, T, Miyagaki, T, Aoki, N, Nakajima, K, Ichiyama, S, Kido-Nakahara, M, Tonomura, K, Nakagawa, Y, Tamagawa-Mineoka, R, Masuda, K, Takeichi, T, Akiyama, M, Ishiuji, Y, Katsuta, M, Kinoshita, Y, Tateishi, C, Yamamoto, A, Morita, A, Matsuda-Hirose, H, Hatano, Y, Kawasaki, H, Tanese, K, Ohtsuki, M, Kamiya, K, Kabata, Y, Abe, R, Mitsui, H, Kawamura, T, Tsuji, G, Katoh, N & Furue, M 2023, 'Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study)', Clinical and Experimental Allergy, vol. 53, no. 2, pp. 233-238. https://doi.org/10.1111/cea.14267

@article{791faa484f8348ad85ce41203b2130f5,

title = "Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study)",

author = "Takeshi Nakahara and Kenji Izuhara and Daisuke Onozuka and Hidehisa Saeki and Satoshi Nunomura and Motoi Takenaka and Mai Matsumoto and Yoko Kataoka and Rai Fujimoto and Sakae Kaneko and Eishin Morita and Akio Tanaka and Michihiro Hide and Tatsuro Okano and Tomomitsu Miyagaki and Natsuko Aoki and Kimiko Nakajima and Susumu Ichiyama and Makiko Kido-Nakahara and Kyoko Tonomura and Yukinobu Nakagawa and Risa Tamagawa-Mineoka and Koji Masuda and Takuya Takeichi and Masashi Akiyama and Yozo Ishiuji and Michie Katsuta and Yuki Kinoshita and Chiharu Tateishi and Aya Yamamoto and Akimichi Morita and Haruna Matsuda-Hirose and Yutaka Hatano and Hiroshi Kawasaki and Keiji Tanese and Mamitaro Ohtsuki and Koji Kamiya and Yudai Kabata and Riichiro Abe and Hiroshi Mitsui and Tatsuyoshi Kawamura and Gaku Tsuji and Norito Katoh and Masutaka Furue",

note = "Funding Information: This work was supported by funding from Sanofi and Regeneron (SGZ‐2018‐11996). The investigators designed the study, collected and analysed the data independently, without interference from the pharmaceutical companies. ",

year = "2023",

month = feb,

doi = "10.1111/cea.14267",

language = "English",

volume = "53",

pages = "233--238",

journal = "Clinical and Experimental Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study)

AU - Nakahara, Takeshi

AU - Izuhara, Kenji

AU - Onozuka, Daisuke

AU - Saeki, Hidehisa

AU - Nunomura, Satoshi

AU - Takenaka, Motoi

AU - Matsumoto, Mai

AU - Kataoka, Yoko

AU - Fujimoto, Rai

AU - Kaneko, Sakae

AU - Morita, Eishin

AU - Tanaka, Akio

AU - Hide, Michihiro

AU - Okano, Tatsuro

AU - Miyagaki, Tomomitsu

AU - Aoki, Natsuko

AU - Nakajima, Kimiko

AU - Ichiyama, Susumu

AU - Kido-Nakahara, Makiko

AU - Tonomura, Kyoko

AU - Nakagawa, Yukinobu

AU - Tamagawa-Mineoka, Risa

AU - Masuda, Koji

AU - Takeichi, Takuya

AU - Akiyama, Masashi

AU - Ishiuji, Yozo

AU - Katsuta, Michie

AU - Kinoshita, Yuki

AU - Tateishi, Chiharu

AU - Yamamoto, Aya

AU - Morita, Akimichi

AU - Matsuda-Hirose, Haruna

AU - Hatano, Yutaka

AU - Kawasaki, Hiroshi

AU - Tanese, Keiji

AU - Ohtsuki, Mamitaro

AU - Kamiya, Koji

AU - Kabata, Yudai

AU - Abe, Riichiro

AU - Mitsui, Hiroshi

AU - Kawamura, Tatsuyoshi

AU - Tsuji, Gaku

AU - Katoh, Norito

AU - Furue, Masutaka

N1 - Funding Information: This work was supported by funding from Sanofi and Regeneron (SGZ‐2018‐11996). The investigators designed the study, collected and analysed the data independently, without interference from the pharmaceutical companies.

PY - 2023/2

Y1 - 2023/2

UR - http://www.scopus.com/inward/record.url?scp=85144213887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85144213887&partnerID=8YFLogxK

U2 - 10.1111/cea.14267

DO - 10.1111/cea.14267

M3 - Letter

C2 - 36524532

AN - SCOPUS:85144213887

SN - 0954-7894

VL - 53

SP - 233

EP - 238

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

IS - 2

ER -

Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study)

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this